ST1613 Anti-TXNDC4 Mouse mAb (3C7)

ST1613
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service
      View Pricing & Availability

      Overview

      Replacement Information

      Key Specifications Table

      Species ReactivityHostAntibody Type
      H M Monoclonal Antibody

      Pricing & Availability

      Catalog Number AvailabilityPackaging Qty/Pack Price Quantity
      ST1613-100UG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service
          Contact Customer Service

          100 μg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewRecognizes the ~45-48 kDa TXNDC4 protein in A431 and K-562 cells and human small intestine tissue.
          Catalogue NumberST1613
          Brand Family Calbiochem®
          SynonymsAnti-Thioredoxin Domain Containing 4
          Application Data
          Detection of human TXNDC4 by immunoblotting. Sample: Whole cell lysate from A431 cells. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (1-5 µg/ml). Detection: chemiluminescence.

          Detection of human TXNDC4 by immunoblotting. Sample: Whole cell lysate from K562 cells. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (1-5 µg/ml). Detection: chemiluminescence.

          Detection of human TXNDC4 by staining paraffin sections. Sample: Formalin-fixed, paraffin embedded human small intestine tissue. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (3 µg/ml). Detection: colorimetric (DAB).
          References
          Product Information
          FormLiquid
          FormulationIn PBS, pH 7.2.
          Negative control293T cells
          Positive controlA431 cells, K-562 cells, Human small intestine tissue
          PreservativeNone
          Applications
          Key Applications Immunoblotting (Western Blotting)
          Paraffin Sections
          Application NotesImmunoblotting (1-5 µg/ml)
          Paraffin sections (3 µg/ml)
          Application CommentsVariables associated with assay conditions will dictate the proper working dilution.
          Biological Information
          ImmunogenFull-length, recombinant human TXNDC4 (aa 30-407), expressed as a GST fusion protein
          Clone3C7
          HostMouse
          IsotypeIgG2b
          Species Reactivity
          • Human
          Antibody TypeMonoclonal Antibody
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Blue Ice Only
          Toxicity Regulatory Review
          Storage -20°C
          Do not freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          Anti-TXNDC4 Mouse mAb (3C7) SDS

          Title

          Safety Data Sheet (SDS) 

          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision09-November-2010 RFH
          SynonymsAnti-Thioredoxin Domain Containing 4
          ApplicationImmunoblotting (1-5 µg/ml)
          Paraffin sections (3 µg/ml)
          Application Data
          Detection of human TXNDC4 by immunoblotting. Sample: Whole cell lysate from A431 cells. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (1-5 µg/ml). Detection: chemiluminescence.

          Detection of human TXNDC4 by immunoblotting. Sample: Whole cell lysate from K562 cells. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (1-5 µg/ml). Detection: chemiluminescence.

          Detection of human TXNDC4 by staining paraffin sections. Sample: Formalin-fixed, paraffin embedded human small intestine tissue. Primary antibody: Anti-TXNDC4 Mouse mAb (3C7) (Cat. No. ST1613) (3 µg/ml). Detection: colorimetric (DAB).
          DescriptionPurified mouse monoclonal antibody. Recognizes the ~45-48 kDa TXNDC4 protein.
          BackgroundMediates thiol-dependent retention in the early secretory pathway, forming mixed disulfides with substrate proteins through its conserved CRFS motif. Inhibits the calcium channel activity of ITPR1. May have a role in the control of oxidative protein folding in the endoplasmic reticulum. Required to retain ERO1L and ERO1LB in the endoplasmic reticulum.
          HostMouse
          ImmunogenFull-length, recombinant human TXNDC4 (aa 30-407), expressed as a GST fusion protein
          Clone3C7
          IsotypeIgG2b
          Specieshuman
          Positive controlA431 cells, K-562 cells, Human small intestine tissue
          Negative control293T cells
          FormLiquid
          FormulationIn PBS, pH 7.2.
          PreservativeNone
          CommentsVariables associated with assay conditions will dictate the proper working dilution.
          Storage -20°C
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing initial thaw, aliquot and freeze (-20°C).
          Toxicity Regulatory Review